Document:

EX-10.19

 Exhibit 10.19 

EMPLOYMENT AGREEMENT 

This AGREEMENT, dated as of             , 2013 (the “Agreement”),
by and among Surgical Care Affiliates, Inc. (the “Parent”), Surgical Care Affiliates LLC (the “Employer” and together with the Parent, the “Company”) and Richard L. Sharff, Jr. (the
“Executive”). 
 WHEREAS, the Company and the Executive desire that any existing agreements related to the Executive’s
employment with the Employer or any of its affiliates, including the Employment Agreement between the Parent, the Employer and the Executive, dated July 24, 2007, as amended (the “Original Agreement”), but not including stock
option and restricted stock unit grant agreements outstanding on the date hereof, be superseded by this Agreement and be of no further force or effect (except as otherwise provided herein); and 

WHEREAS, the Company desires that the Executive serve the Company as its Executive Vice President and General Counsel on the terms and
conditions set forth herein. 
 NOW, THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable
consideration, the parties agree as follows: 
  

	 	1.	Employment, Duties and Agreements. 

 (a) The Company hereby agrees to employ the
Executive as its Executive Vice President and General Counsel, and the Executive hereby accepts such position and agrees to serve the Company in such capacity during the employment period fixed by Section 3 hereof (the “Employment
Period”). The Executive shall report to the Chief Executive Officer of the Company or its designee and shall have such duties and responsibilities as are consistent with the Executive’s position. During the Employment Period, the
Executive shall be subject to, and shall act in accordance with, all reasonable instructions and directions, and all applicable policies and rules, of the Company, including without limitation any policy with respect to equity hedging. The
Executive’s principal work location shall be at the Company’s offices in Birmingham, Alabama or such other location as the Executive and the Company shall mutually agree, (hereinafter the “Principal Place of Business”)
provided that the Executive may be required to travel as necessary in order to perform his duties and responsibilities hereunder. 
 (b)
During the Employment Period, excluding any periods of vacation and sick leave to which the Executive is entitled, the Executive shall devote his full working time, energy and attention to the performance of his duties and responsibilities hereunder
and shall faithfully and diligently endeavor to promote the business and best interests of the Company. 
 (c) During the Employment Period,
the Executive may not, without the prior written consent of the Board of Directors of the Parent (the “Board”), which consent shall not be unreasonably withheld, directly or indirectly, operate, participate in the management,
operations or control of, or act as an executive, officer, consultant, agent or representative of, any type of business or service (other than as an executive of the Company), provided that it shall not be a violation of the foregoing for the
Executive to (i) continue to serve on the board of another company of which the Executive is currently serving, as set forth on Exhibit A hereto, provided that such companies are not competitors of the Company; (ii) serve on the
board of directors of trade associations and/or charitable organizations; (iii) engage in charitable activities and community affairs; and (iv) manage his personal investments and affairs; provided that the activities described in
the preceding clauses (i) through (iv) do not interfere with the proper performance of his duties and responsibilities hereunder. 

(d) Notwithstanding anything to the contrary herein, this Agreement supersedes any existing agreements related to the Executive’s
employment with the Company or any of its affiliates, including the Original Agreement, but not including stock option and restricted stock unit grant agreements outstanding on the date hereof, and such agreements shall be of no further force or
effect. 

	 	2.	Compensation. 

 (a) As compensation for the agreements made by the Executive herein and
the performance by the Executive of his obligations hereunder, during the Employment Period, the Employer shall pay the Executive, pursuant to the Employer’s normal and customary payroll procedures, a base salary at the rate of $325,000 per
annum, (the “Base Salary”), subject to annual review and increases as determined by the Board in its discretion; provided that effective January 1, 2014, the Executive’s Base Salary shall be $400,000 per annum. 

(b) In addition to the Base Salary, during the Employment Period, the Executive shall be eligible to participate in the executive bonus
program (the “Program”), to be established and approved by the Board from time to time and, pursuant to the Program, the Executive may earn an annual bonus (the “Annual Bonus”) in each fiscal year during the
Employment Period, with a target Annual Bonus of 60% of Base Salary up to a maximum of 120% of Base Salary, based on the achievement of annual performance objectives as set forth in the Program, subject to the Executive’s employment with the
Company through the applicable payment date for any such Annual Bonus (except as otherwise provided herein), Annual Bonuses shall be paid as soon as practicable following the end of the fiscal year to which such Annual Bonus relates, and in any
event no later than March 31 of the year following such fiscal year. 
 (c) During the Employment Period, the Executive shall be
eligible to participate in the equity or equity-based incentive plans of the Parent as may be established by the Board from time to time, subject to the terms and conditions thereof. 

(d) During the Employment Period, the Executive and his eligible dependents shall be entitled to participate in all welfare benefit and
savings and retirement plans, practices, policies and programs of the Employer (including the Employer’s health insurance and disability plans) provided by the Employer which are made available generally to other executive officers of the
Company (for the avoidance of doubt, such plans, practices, policies or programs shall not include any plan, practice, policy or program which provides benefits in the nature of severance or continuation pay). 

(e) The Employer shall reimburse the Executive for all reasonable business expenses upon the presentation of statements of such expenses in
accordance with the Company’s policies and procedures now in force or as such policies and procedures may be modified with respect to all senior executive officers of the Company. 

 

	 	3.	Employment Period. 

 The Employment Period shall be effective as of the date hereof (the
“Effective Date”) and shall terminate on the third anniversary of the Effective Date, provided that on the third anniversary of the Effective Date and on each anniversary thereafter, the Employment Period shall automatically be
extended for additional one-year periods unless either party provides the other party with notice of non-renewal at least ninety (90) days before any such anniversary (the anniversary date on which the Employment Period terminates shall be
referred to herein as the “Scheduled Termination Date”). Notwithstanding the foregoing, the Executive’s employment hereunder may be terminated during the Employment Period prior to the Scheduled Termination Date upon the
earliest to occur of the following events (at which time the Employment Period shall be terminated): 
 (a) Death. The
Executive’s employment hereunder shall terminate upon his death. 

  
 2 

 (b) Disability. The Company shall be entitled to terminate the Executive’s employment
hereunder for “Disability” if, as a result of the Executive’s incapacity due to physical or mental illness or injury, the Executive (i) shall become eligible to receive a benefit under the Company’s long-term disability plan
applicable to the Executive, or (ii) the Executive has been unable, due to physical or mental illness or incapacity, to perform the essential duties of his employment with reasonable accommodation for a continuous period of 90 days or an
aggregate of 180 days. 
 (c) Cause. The Company may terminate the Executive’s employment hereunder for Cause. For purposes of
this Agreement, the term “Cause” shall mean: (i) the Executive’s act of fraud, misappropriation, or embezzlement with respect to the Company; (ii) the Executive’s indictment for, conviction of, or plea of guilty
or no contest to, any felony; (iii) the suspension or debarment of the Executive or of the Company or any of its affiliated companies or entities as a direct result of any act or omission of the Executive in connection with his employment with
the Company from participation in any Federal or state health care program; (iv) the Executive’s admission of liability of, or finding of liability for, the willful violation of any “Securities Laws” (as hereinafter defined);
(v) the Executive’s repeated failure after reasonable prior written notice to comply with any valid and legal directive of the Chief Executive Officer or the Board; or (vi) other than as provided in Sections 3(c)(i) —
(v) above, the Executive’s breach of any material provision of this Agreement that is not remedied within fifteen (15) days of the Executive being provided written notice thereof from the Company. Repeated breaches of a similar
nature, such as the failure to report to work, perform duties, or follow directions, all as provided herein, shall not require additional notices as provided Section 3(c)(vi). As used herein, the term “Securities Laws” means
any Federal or state law, rule or regulation governing the issuance or exchange of securities, including without limitation the Securities Act of 1933, the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder. 

(d) Without Cause. The Company may terminate the Executive’s employment hereunder during the Employment Period without Cause,
which shall include the Company providing notice of non-renewal of this Agreement prior to any Scheduled Termination Date pursuant to and in accordance with Section 3 hereof. 

(e) For Good Reason. The Executive may terminate this Agreement at any time upon sixty (60) days’ prior written notice to the
Company and the Company fails to cure such event within such sixty (60)-day period (any such termination referenced in clauses (i) — (v) below, unless the Executive shall have consented in writing thereto, constituting termination for
“Good Reason”): (i) if the Company fails to make all or any portion of any payment required by Sections 2(a) and (b) hereof within a reasonable time after such payments are due; (ii) if the Company materially modifies
the Program such that the targeted cash bonus levels described in Section 2(b) herein and applicable to the Executive are lower than those levels of other similarly-situated executive officers of the Company; (iii) upon a material
diminution of the Executive’s duties, responsibilities or positions, including without limitation an adverse change to his reporting relationships as set forth in Section 1(a) of this Agreement; (iv) the relocation of the
Executive’s work location set forth in Section 1(a) more than fifty (50) miles from the Principal Place of Business; and/or (v) except as otherwise set forth in clauses (i) through (iv) above, if the Company materially
breaches any of its other duties or obligations hereunder. 
 (f) Voluntarily. The Executive may voluntarily terminate his employment
hereunder (other than for Good Reason), provided that the Executive provides the Company with notice of his intent to terminate his employment at least sixty (60) days in advance of the Date of Termination (as defined in Section 4 below).

  
 3 

	 	4.	Termination Procedure. 

 (a) Notice of Termination. Any termination of the
Executive’s employment by the Company or by the Executive during the Employment Period (other than a termination on account of the death of Executive) shall be communicated by written “Notice of Termination” to the other party hereto
in accordance with Section 12(a). 
 (b) Date of Termination. “Date of Termination” shall mean (i) if the
Executive’s employment is terminated by his death, the date of his death, (ii) if the Executive’s employment is terminated pursuant to Section 3(b), on the date the Executive receives Notice of Termination from the Company,
(iii) if the Executive voluntarily terminates his employment (including for Good Reason), the date specified in the notice given pursuant to Section 3(e) or (f) herein, as applicable, which shall not be less than sixty (60) days
after the Notice of Termination, and (iv) if the Executive’s employment is terminated for any other reason, the date on which a Notice of Termination is given or any later date (within thirty (30) days, or any alternative time period
agreed upon by the parties, after the giving of such notice) set forth in such Notice of Termination; provided, that, the Company may terminate the Executive’s employment at any time for Cause. 

 

	 	5.	Termination Payments. 

 (a) Without Cause or for Good Reason. In the event of the
termination of the Executive’s employment during the Employment Period (i) by the Company without Cause, (ii) by the Executive for Good Reason or (iii) if the Company provides a notice of non-renewal of the Employment Period
under Section 3, by the Executive or the Company for any reason effective at any time on or after the Scheduled Termination Date, and in each case other than a CIC Termination described in Section 5(d), during the eighteen (18) months
following the Date of Termination (the “Salary Continuation Period”) the Executive shall receive, in addition to his accrued but unused vacation and Base Salary through the Date of Termination and any Annual Bonus in respect of the
prior fiscal year (to the extent earned but not theretofore paid), salary continuation payments paid in accordance with the Company’s normal and customary payroll practices at the same rate as the Executive’s annual Base Salary. On the
date that bonuses are otherwise paid to participants in the Program, a single lump sum payment will be payable equal to the Executive’s Annual Bonus, based upon achievement of performance objectives as set forth in the Program, multiplied by a
fraction, the numerator of which is the number of full weeks in the period beginning on the first day of the then-current annual performance period and ending on the Date of Termination and the denominator of which is fifty two (the “Pro
Rata Bonus”). In addition, during the eighteen (18) month period following the Date of Termination, the Company shall continue to provide medical benefits to the Executive which are (and on terms which are) substantially similar to
those provided generally to executive officers of the Company pursuant to such medical plan as may be in effect from time to time (it being understood that the Company may provide such coverage by paying the Executive’s COBRA premiums, less any
contribution required by the Executive consistent with the contributions required of similarly situated executives who continue to be employed by the Company); provided, however, that if the Executive becomes re-employed with another employer
and is eligible to receive health insurance benefits under another employer provided plan, the Executive is obligated to promptly notify the Company of any changes in his benefits coverage and the Company reimbursements described herein shall
terminate (the “Continued Healthcare Benefit”). The Executive also shall be entitled to reimbursement of any and all reasonable business expenses incurred in connection with the Executive’s duties and responsibilities under
this Agreement in accordance with Company policy, to the extent not previously reimbursed. The salary continuation payments, the Pro Rata Bonus and reimbursement for COBRA (as such term is defined below) continuation coverage are subject to and
conditioned upon the Executive executing a valid general release and waiver (in the form acceptable to the Company), waiving all claims the Executive may have against the Company, its successors, assigns,

  
 4 

 
affiliates, executives, officers and directors, and such waiver becoming effective on or before the thirtieth (30th) day following the
Date of Termination, and the payments and benefits are subject to and conditioned upon the Executive’s compliance with the Restrictive Covenants provided in Sections 7 and 8 hereof (together, the “Conditions”). Except as set
forth herein, the Executive shall not be required to mitigate any damages that the Executive may incur as a result of a termination of his employment by the Company without Cause or for Good Reason during the Employment Period. Except as provided in
this Section 5(a), and except for any vested benefits under any tax qualified pension plans of the Company, and continuation of health insurance benefits on the terms and to the extent required by Section 4980B of the Internal Revenue Code
of 1986, as amended (“Code”) and Section 601 of the Employee Retirement Income Security Act of 1974, as amended (which provisions are commonly known as “COBRA”), the Company shall have no additional obligations
under this Agreement. 
 (b) Disability or Death. If the Executive’s employment is terminated during the Employment Period as a
result of the Executive’s death or Disability, the Company shall pay the Executive or the Executive’s estate, as the case may be, within thirty (30) days following the Date of Termination: (i) the Executive’s accrued but
unused vacation; (ii) his accrued but unpaid Base Salary; (iii) any Annual Bonus earned by the Executive in respect of the fiscal year ending immediately prior to the Date of Termination; and (iv) the Pro Rata Bonus (subject to, and
conditioned upon, in the event the Executive’s employment terminated as a result of the Executive’s Disability, the Executive satisfying the Conditions). Except as provided in this Section 5(b), and except for any vested benefits
under any tax qualified pension plans of the Company, and continuation of health insurance benefits on the terms and to the extent required by COBRA, the Company shall have no additional obligations under this Agreement. 

(c) Cause or Voluntarily. If the Executive’s employment is terminated during the Employment Period by the Company for Cause or
voluntarily by the Executive other than for Good Reason, the Company shall pay the Executive within thirty (30) days following the Date of Termination: (i) the Executive’s accrued but unused vacation through the Date of Termination;
and (ii) his accrued but unpaid Base Salary through the Date of Termination. Except as provided in this Section 5(c) and except for any vested benefits under any tax qualified pension plans of the Company, and continuation of health
insurance benefits on the terms and to the extent required by COBRA, the Company shall have no additional obligations under this Agreement. 

(d) Change in Control Termination. In lieu of the payments and benefits described in Section 5(a) above, but subject to and
conditioned upon the Executive satisfying the Conditions, in the event the Executive’s employment is terminated (x) by the Company without Cause, (y) by the Executive for Good Reason or (z) if the Company provides a notice of
non-renewal of the Employment Period under Section 3, by the Executive or the Company for any reason effective at any time on or after the Scheduled Termination Date, and in each such case occurring within the three (3) months prior to the
consummation of, or within the twenty-four (24) month period following the occurrence of, a Change in Control (such termination, a “CIC Termination”), the Executive shall be entitled to, in addition to his accrued but unused
vacation and Base Salary through the Date of Termination and any Annual Bonus in respect of the prior fiscal year (to the extent earned but not theretofore paid), subject to the Executive satisfying the Conditions (i) an amount equal to one and
one-half times (1.5x) the sum of (A) the Executive’s then-current Base Salary and (B) the Executive’s target Annual Bonus, payable in a lump sum within forty (40) days following the date of such CIC Termination,
(ii) the Pro Rata Bonus, and (iii) the Continued Healthcare Benefit. For purposes of this Agreement, “Change in Control” shall mean a change in the ownership or effective control of the Company, or a change in the
ownership of a substantial portion of the assets of the Company, within the meaning of Section 409A(a)(2)(A)(v) of the Code and U.S. Treasury Regulation Section 1.409A-3(i)(5). Except as provided in this Section 5(d) and except for
any vested benefits under any tax qualified pension plans of the Company, and continuation of health insurance benefits on the terms and to the extent required by COBRA, the Company shall have no additional obligations under this Agreement. 

  
 5 

	 	6.	Legal Fees; Indemnification; Officers’ Liability Insurance. 

 (a) In the event of
any contest or dispute between the Company and the Executive with respect to this Agreement or the Executive’s employment hereunder, each of the parties shall be responsible for its respective legal fees and expenses; provided that in
the event of any dispute between the Company and the Executive that arises during the three (3) months preceding or at any time following the occurrence of a Change in Control, the Company shall be responsible for reimbursing the Executive for
the Executive’s reasonable legal fees and expenses in the event that the Executive prevails on at least one material issue central to the dispute in a final, non-appealable judgment of such dispute. 

(b) During the Employment Period and thereafter with regard to the Executive’s activities during the Employment Period on behalf of the
Company, its subsidiaries or affiliates, or as a fiduciary of any benefit plan of any of them, the Company shall indemnify the Executive to the fullest extent permitted by applicable law (other than in connection with the Executive’s gross
negligence or willful misconduct), and shall at the Company’s election provide the Executive with legal representation or shall advance to the Executive reasonable attorneys’ fees and expenses as such fees and expenses are incurred
(subject to an undertaking from the Executive to repay such advances if it shall be finally determined by a judicial decision which is not subject to further appeal that the Executive was not entitled to the reimbursement of such fees and expenses).
During the Employment Period, the Executive shall be entitled to the same directors’ and officers’ liability insurance coverage that the Company provides generally to its other directors and officers, as may be amended from time to time
for such directors and officers. 
  

	 	7.	Non-Solicitation. 

 During the Employment Period and for eighteen (18) months
thereafter, the Executive hereby agrees not to, directly or indirectly, solicit or assist any other Person (as defined below) in soliciting any employee of the Company or any of its affiliates to perform services for any entity (other than the
Company or its affiliates), attempt to induce any such employee to leave the employ of the Company or its affiliates, or hire or engage on behalf of himself or any other Person any employee of the Company or anyone who was employed by the Company
during the six-month period preceding such hiring or engagement. An individual’s response to a broad and general advertisement or solicitation not specifically targeting or intending to target employees of the Company, its subsidiaries or any
of affiliates shall not be deemed a violation of this Section 7. 
  

	 	8.	Confidentiality; Non-Compete; Non-Disclosure; Non-Disparagement. 

 (a) The Executive
hereby agrees that, during the Employment Period and thereafter, he will hold in strict confidence any proprietary or Confidential Information related to the Company and its affiliates. For purposes of this Agreement, the term “Confidential
Information” shall mean all information of the Company or any of its affiliates (in whatever form) which is not generally known to the public, including without limitation any inventions, processes, methods of distribution, customer lists
or customers’ or trade secrets. 
 (b) The Executive and the Company agree that the Company would likely suffer significant harm from
the Executive’s competing with the Company during the Employment Period and for some period of time thereafter. Accordingly, the Executive agrees that he will not, during the Employment Period and for a period of eighteen (18) months
following the termination of the 

  
 6 

 
Employment Period for any reason, directly or indirectly, become employed by, engage in business with, serve as an agent or consultant to, become a partner, member, principal, stockholder or
other owner (other than a holder of less than 1% of the outstanding voting shares of any publicly held company) of, or otherwise perform services relating to, the Business (as defined below) for any Person that is engaged in, or otherwise competes
or has a reasonable potential for competing with the Business (as defined herein), anywhere in which the Company or its subsidiaries engage in or intend to engage in the Business or where the Company or its subsidiaries’ customers are located
(whether or not for compensation); provided, that this Section 8 shall not restrict or prohibit the Executive from providing legal services to any Person to the extent any such restriction or prohibition violates the applicable law of any
jurisdiction in which the Executive is admitted to practice law or the rules of professional conduct of any such jurisdiction, and provided further, that any such restriction or prohibition shall be null and void and of no force or effect solely to
the extent required by such applicable law or rules of professional conduct. For purposes of Sections 7 and 8, the term “Person” shall mean any individual, partnership, corporation, limited liability company, unincorporated
organization, trust or joint venture, or a governmental agency or political subdivision thereof. For purposes of Sections 7 and 8, the “Business” shall mean the operation and administration of a network of ambulatory surgical care
centers or surgical hospitals providing facilities and medical staff (with re-syndication of ownership interests by participating physicians). 

(c) The Executive hereby agrees that upon the termination of the Employment Period, he shall not take, without the prior written consent of
the Company, any Confidential Information, including without limitation any business plans, contact lists, strategic plans or reports or other document (in whatever form) of the Company or its affiliates, relating to its or their methods of
distribution, or any description of any formulas or secret processes and will return any such information (in whatever form) then in his possession. 

(d) The Executive hereby agrees not to defame or disparage the Company, its affiliates and their officers, directors, members or executives.
The Executive hereby agrees to cooperate with the Company in refuting any defamatory or disparaging remarks by any third party made in respect of the Company or its affiliates or their directors, members, officers or executives. 

 

	 	9.	Injunctive Relief. 

 It is impossible to measure in money the damages that will accrue to
the Company in the event that the Executive breaches any of the restrictive covenants provided in Sections 7 and 8 hereof. In the event that the Executive breaches any such restrictive covenant, the Company shall be entitled to an injunction
restraining the Executive from violating such restrictive covenant (without posting any bond). If the Company shall institute any action or proceeding to enforce any such restrictive covenant, the Executive hereby waives the claim or defense that
the Company has an adequate remedy at law and agrees not to assert in any such action or proceeding the claim or defense that the Company has an adequate remedy at law. The foregoing shall not prejudice the Company’s right to require the
Executive to account for and pay over to the Company, and the Executive hereby agrees to account for and pay over, the compensation, profits, monies, accruals or other benefits derived or received by the Executive as a result of any transaction
constituting a breach of any of the restrictive covenants provided in Sections 7 and 8 hereof. 
  

	 	10.	Section 280G. 

 Notwithstanding any other provision of this Agreement or any other
plan, arrangement, or agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company or its affiliates to the Executive or for the Executive’s benefit pursuant to the terms of this

  
 7 

 
Agreement or otherwise (“Covered Payments”) constitute parachute payments (“Parachute Payments”) within the meaning of Section 280G of the Code and would,
but for this Section 10 be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any similar tax imposed by state or local law or any interest or penalties with respect to such taxes
(collectively, the “Excise Tax”), then the Covered Payments shall be payable either (i) in full or (ii) reduced to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise
Tax, whichever of the foregoing (i) or (ii) results in the Executive’s receipt on an after-tax basis of the greatest amount of benefits after taking into account the applicable federal, state, local and foreign income, employment and
excise taxes (including the Excise Tax). If Covered Payments are reduced, such Covered Payments shall be reduced in a manner that maximizes the Executive’s economic position. In applying this principle, the reduction shall be made in a manner
consistent with the requirements of Section 409A of the Code, to the extent applicable, and where two or more economically equivalent amounts are subject to reduction but payable at different times, such amounts payable at the later time shall
be reduced first but not below zero (0). 
  

	 	11.	Representations. 

 The parties hereto hereby represent that they each have the authority
to enter into this Agreement, and the Executive hereby represents to the Company that the execution of, and performance of duties under, this Agreement shall not constitute a breach of or otherwise violate any other agreement to which the Executive
is a party. 
  

	 	12.	Miscellaneous. 

 (a) Any notice or other communication required or permitted under this
Agreement shall be effective only if it is in writing and shall be deemed to be given when delivered personally or four days after it is mailed by registered or certified mail, postage prepaid, return receipt requested or one day after it is sent by
a reputable overnight courier service and, in each case, addressed as follows (or if it is sent through any other method agreed upon by the parties): 

If to the Parent: 
 Surgical Care
Affiliates, Inc. 
 Attn: General Counsel 

P.O. Box 382497 
 Birmingham, AL
35238-2497 
 With a copy to: 

Robert J. Raymond 
 Cleary
Gottlieb Steen & Hamilton LLP 
 One Liberty Plaza 

New York, NY 10006 
 If to the
Employer: 
 Surgical Care Affiliates LLC 

Attn: General Counsel 
 P.O. Box
382497 
 Birmingham, AL 35238-2497 

  
 8 

 With a copy to: 

Robert J. Raymond 
 Cleary
Gottlieb Steen & Hamilton LLP 
 One Liberty Plaza 

New York, NY 10006 
 If to the
Executive: 
 At his most recent address shown on the payroll records of the Company 

or to such other address as any party hereto may designate by notice to the others. 

(b) This Agreement shall constitute the entire agreement among the parties hereto with respect to the matters set forth hereunder, and
supersedes and is in full substitution for any and all prior understandings or agreements with respect to such matters, including the Original Agreement except (i) with respect to the Executive’s rights to amounts that are earned and
vested prior to the Effective Date, and (ii) that Section 6(b) shall survive with respect to acts and omissions prior to the Effective Date. 

(c) This Agreement may be amended only by an instrument in writing signed by the parties hereto, and any provision hereof may be waived only
by an instrument in writing signed by the party or parties against whom or which enforcement of such waiver is sought. The failure of any party hereto at any time to require the performance by any other party hereto of any provision hereof shall in
no way affect the full right to require such performance at any time thereafter, nor shall the waiver by any party hereto of a breach of any provision hereof be taken or held to be a waiver of any succeeding breach of such provision or a waiver of
the provision itself or a waiver of any other provision of this Agreement. 
 (d) The parties hereto acknowledge and agree that each party
has reviewed and negotiated the terms and provisions of this Agreement and has had the opportunity to contribute to its revision. Accordingly, the rule of construction to the effect that ambiguities are resolved against the drafting party shall not
be employed in the interpretation of this Agreement. Rather, the terms of this Agreement shall be construed fairly as to both parties hereto and not in favor or against either party. 

(e) This Agreement is binding on and is for the benefit of the parties hereto and their respective successors, assigns, heirs, executors,
administrators and other legal representatives. Neither this Agreement nor any right or obligation hereunder may be assigned by the Executive. 

(f) The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such succession had taken place. As used in the
Agreement, “the Company” shall mean both the Company as defined above and any such successor that assumes this Agreement, by operation of law or otherwise. 

(g) Any provision of this Agreement (or portion thereof) which is deemed invalid, illegal or unenforceable in any jurisdiction shall, as to
that jurisdiction and subject to this Section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such jurisdiction or rendering that or any other
provisions of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant shall be modified so that the
scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement by the Company shall be implied by the Company’s
forbearance or failure to take action. 

  
 9 

 (h) The intent of the parties is that payments and benefits under this Agreement comply with
Section 409A of the Code and the regulations and guidance promulgated thereunder (except to the extent exempt as short-term deferrals or otherwise) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in
compliance therewith. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits subject to Section 409A of the Code upon or following a
termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A of the Code and, for purposes of any such provision of this Agreement, references to a “termination,”
“termination of employment,” “termination of the Term of Employment” or like terms shall mean “separation from service.” The determination of whether and when a separation from service has occurred shall be made in a
manner consistent with, and based on the presumptions set forth in, U.S. Treasury Regulation Section 1.409A-1(h) or any successor provision thereto. It is intended that each installment, if any, of the payments and benefits provided hereunder
shall be treated as a separate “payment” for purposes of Section 409A of the Code. Neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent
specifically permitted or required by Section 409A of the Code; and if, as of the date of the “separation from service,” the Executive is a “specified employee” (within the meaning of that term under
Section 409A(a)(2)(B) of the Code, or any successor provision thereto), then with regard to any payment or the provision of any benefit that is subject to this section (whether under this Agreement, or pursuant to any other agreement with or
plan, program, payroll practice of the Company) and is due upon or as a result of the Executive’s separation from service, such payment or benefit shall not be made or provided, to the extent making or providing such payment or benefit would
result in additional taxes or interest under Section 409A of the Code, until the date which is the earlier of (i) the expiration of the six (6)-month period measured from the date of such “separation from service,” and
(ii) the date of the Executive’s death (the “Delay Period”) and this Agreement and each such agreement, plan, program, or payroll practice shall hereby be deemed amended accordingly. Upon the expiration of the Delay
Period, all payments and benefits delayed pursuant to this Section 12(h) (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump
sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. All reimbursements and in-kind benefits provided under this Agreement or otherwise
to the Executive shall be made or provided in accordance with the requirements of Section 409A of the Code to the extent that such reimbursements or in-kind benefits are subject to Section 409A of the Code. All expenses or other
reimbursements paid pursuant herewith and therewith that are taxable income to Executive shall in no event be paid later than the end of the calendar year next following the calendar year in which Executive incurs such expense or pays such related
tax. With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Section 409A of the Code, the right to reimbursement or in-kind benefits shall not be subject to
liquidation or exchange for another benefit, the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in
any other taxable year, provided that, the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the
period the arrangement is in effect and such payments shall be made on or before the last day of Executive’s taxable year following the taxable year in which the expense occurred. 

(i) This Agreement shall be governed by and construed in accordance with the laws of the State of Alabama without reference to its principles
of conflicts of law. 

  
 10 

 (j) This Agreement may be executed in several counterparts, each of which shall be deemed an
original, but all of which shall constitute one and the same instrument. A facsimile of a signature shall be deemed to be and have the effect of an original signature. 

(k) The headings in this Agreement are inserted for convenience of reference only and shall not be a part of or control or affect the meaning
of any provision hereof. 
 *  *  *  *  *  * 

  
 11 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

	
	SURGICAL CARE AFFILIATES, INC.
	
	  

	Name:
	Title:
	
	SURGICAL CARE AFFILIATES LLC
	
	  

	Name:
	Title:
	
	  

	Richard L. Sharff, Jr.

  
 12 

 EXHIBIT A 

  
 13EX-10.24

 Exhibit 10.24 
  

 
  

STOCKHOLDERS AGREEMENT 

BY AND AMONG 
 SURGICAL
CARE AFFILIATES, INC. 
 AND 

THE STOCKHOLDERS PARTY HERETO 

DATED AS OF            , 2013

  
  

 

 TABLE OF CONTENTS 

 

							
	Article I DEFINITIONS	  	 	1	  
			
	 Section 1.1
	  	Definitions	  	 	1	  
			
	 Section 1.2
	  	Other Interpretive Provisions	  	 	4	  
		
	Article II REPRESENTATIONS AND WARRANTIES	  	 	5	  
			
	 Section 2.1
	  	Existence; Authority; Enforceability	  	 	5	  
			
	 Section 2.2
	  	Absence of Conflicts	  	 	5	  
			
	 Section 2.3
	  	Consents	  	 	5	  
		
	Article III GOVERNANCE	  	 	5	  
			
	 Section 3.1
	  	The Board	  	 	5	  
			
	 Section 3.2
	  	Voting Agreement	  	 	10	  
			
	 Section 3.3
	  	The Boards of Directors of Subsidiaries	  	 	10	  
		
	Article IV GENERAL PROVISIONS	  	 	10	  
			
	 Section 4.1
	  	Company Charter and Company Bylaws	  	 	10	  
			
	 Section 4.2
	  	Corporate Opportunities	  	 	10	  
			
	 Section 4.3
	  	Assignment; Benefit	  	 	12	  
			
	 Section 4.4
	  	Confidentiality	  	 	12	  
			
	 Section 4.5
	  	Termination	  	 	13	  
			
	 Section 4.6
	  	Severability	  	 	13	  
			
	 Section 4.7
	  	Entire Agreement; Amendment	  	 	14	  
			
	 Section 4.8
	  	Counterparts	  	 	14	  
			
	 Section 4.9
	  	Notices	  	 	14	  
			
	 Section 4.10
	  	Governing Law	  	 	15	  
			
	 Section 4.11
	  	Jurisdiction	  	 	16	  
			
	 Section 4.12
	  	Waiver of Jury Trial	  	 	16	  
			
	 Section 4.13
	  	Specific Performance	  	 	16	  
			
	 Section 4.14
	  	Subsequent Acquisition of Shares	  	 	16	  

  
 i 

 This STOCKHOLDERS AGREEMENT (as it may be amended from time to time in accordance with the terms
hereof, the “Agreement”), dated as of             , 2013, is made by and among: 

i. Surgical Care Affiliates, Inc., a Delaware corporation (the “Company”); 

ii. TPG Partners V, L.P., TPG FOF V-A, L.P. and TPG FOF V-B, L.P. (together with their Affiliates, “TPG” or the “TPG
Investors”); and 
 iii. such other Persons who from time to time become party hereto by executing a counterpart signature page
hereof and are designated by the Board (as defined below) as “Other Stockholders” (the “Other Stockholders” and, together with the TPG Investors, the “Stockholders”). 

RECITALS 
 WHEREAS, on
August 22, 2007, the TPG Investors and certain other co-investors entered into the Second Amended and Restated Limited Liability Company Operating Agreement of ASC Acquisition LLC, which contained certain enumerated governance rights; 

WHEREAS, on            , 2013, the Company priced an initial public offering (the
“IPO”) of shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), pursuant to an Underwriting Agreement
dated            , 2013 (the “Underwriting Agreement”); 

WHEREAS, on the date hereof, the Company, which was previously named ASC Acquisition LLC, shall have converted from a limited liability
company organized under the laws of the State of Delaware to a corporation organized under the laws of the State of Delaware, pursuant to the Delaware Limited Liability Company Act, Section 18-216, and the General Corporation Law of the State
of Delaware, Section 265; and 
 WHEREAS, the parties hereto desire to provide for certain governance rights and other matters, and to
set forth the respective rights and obligations of the Stockholders following the IPO. 
 NOW, THEREFORE, in consideration of the foregoing
and the mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 

ARTICLE I 
 DEFINITIONS

 Section 1.1 Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“Affiliate” means, with respect to any specified Person, (a) any Person that directly or indirectly through one or more
intermediaries controls, or is controlled by, or is under 

  
 1 

 
common control with, such specified Person or (b) in the event that the specified Person is a natural Person, a Member of the Immediate Family of such Person; provided that the
Company, and each of its subsidiaries shall not be deemed to be Affiliates of the TPG Investors. As used in this definition, the term “control” means the possession, directly or indirectly, of the power to direct or cause the direction of
the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. 
 “Affiliated
Person” has the meaning set forth in Section 4.4(a). 
 “Agreement” has the meaning set forth in the
Preamble. 
 “Acquired Knowledge” has the meaning set forth in Section 4.2(a). 

“beneficially own” has the meaning set forth in Rule 13d-3 promulgated under the Exchange Act. 

“Board” means the board of directors of the Company. 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law
to be closed in the City of New York, New York. 
 “Chief Executive Officer” means the chief executive officer of the
Company then in office. 
 “Closing” means the closing of the IPO. 

“Common Stock” has the meaning set forth in the Recitals. 

“Company” has the meaning set forth in the Preamble. 

“Company Bylaws” means the by-laws of the Company in effect on the date hereof, as may be amended from time to time. 

“Company Charter” means the certificate of incorporation of the Company in effect on the date hereof, as may be amended from
time to time. 
 “Company Shares” means (i) all shares of Common Stock outstanding at the time of determination,
(ii) all shares of Common Stock issuable upon exercise, conversion or exchange of any option, warrant or convertible security and (iii) all shares of Common Stock directly or indirectly issued or issuable with respect to the securities
referred to in clauses (i) or (ii) above by way of unit or stock dividend or unit or stock split, or in connection with a combination of units or shares, recapitalization, merger, consolidation or other reorganization. 

“Corporate Opportunity” means (i) an investment or business opportunity or activity, including without limitation those
that might be considered the same as or similar to the Company’s business or the business of any Affiliate or any direct or indirect subsidiary of the Company, including those deemed to be competing with the Company or any Affiliate or any
direct or indirect subsidiary of the Company, or (ii) a prospective economic or competitive 

  
 2 

 
advantage in which the Company or any Affiliate or any direct or indirect subsidiary of the Company could have an interest or expectancy. In addition to and notwithstanding the foregoing, a
Corporate Opportunity shall not be deemed to be a potential opportunity for the Company or any Affiliates or any direct or indirect subsidiary if it is a business opportunity that (i) the Company, Affiliate or direct or indirect subsidiary, as
applicable, is not financially able or contractually permitted or legally able to undertake, (ii) from its nature, is not in the line of the Company’s, Affiliate’s or direct or indirect subsidiary’s, as applicable, business or is
of no practical advantage to it or (iii) is one in which the Company, Affiliate or direct or indirect subsidiary, as applicable, has no interest or reasonable expectancy. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and any successor thereto, and any rules and
regulations promulgated thereunder, all as the same shall be in effect from time to time. 
 “First Anniversary of the IPO”
has the meaning set forth in Section 3.1(b). 
 “Fund Indemnitors” has the meaning set forth in Section 3.1(m).

 “Indemnification Agreement” has the meaning set forth in Section 3.1(m). 

“Indemnitee” has the meaning set forth in Section 3.1(m). 

“IPO” has the meaning set forth in the Recitals. 

“Majority in Interest” means, with respect to the Stockholders or any subset thereof, Stockholders who beneficially own a
majority of Company Shares held by the Stockholders or such subset of Stockholders, as applicable. 
 “Member of the Immediate
Family” means, with respect to an individual, (a) each parent, spouse (but not including a former spouse or a spouse from whom such individual is legally separated) or child (including those adopted) of such individual and
(b) each trustee, solely in his or her capacity as trustee and so long as such trustee is reasonably satisfactory to the Company, for a trust naming only one or more of the Persons listed in sub-clause (a) as beneficiaries. 

“Necessary Action” means, with respect to a specified result, all actions necessary, to the fullest extent permitted by
applicable law, to cause such result, including, without limitation, (i) voting or providing a written consent or proxy with respect to the Company Shares, (ii) causing the adoption of stockholders’ resolutions and amendments to the
organizational documents of the Company, (iii) executing agreements and instruments, and (iv) making, or causing to be made, with governmental, administrative or regulatory authorities, all filings, registrations or similar actions that
are required to achieve such result. 
 “Other Stockholders” has the meaning set forth in the Preamble. 

“Person” means any individual, partnership, limited liability company, corporation, trust, association, estate,
unincorporated organization or government or any agency or political subdivision thereof. 

  
 3 

 “Post-IPO TPG Shares” means the number of shares of Common Stock beneficially
owned, in the aggregate, by TPG as of the date of closing of all of the transactions contemplated by the Underwriting Agreement. 

“Representatives” means, with respect to any Person, any of such Person’s officers, directors, employees, agents,
attorneys, accountants, actuaries, consultants or financial advisors or other Person associated with, or acting on behalf of, such Person. 

“Securities Act” means the Securities Act of 1933, as amended, and any successor thereto, and any rules and regulations
promulgated thereunder, all as the same shall be in effect from time to time. 
 “Stockholders” has the meaning set forth
in the Preamble. 
 “TPG” or “TPG Investors” has the meaning set forth in the Preamble. 

“TPG Affiliated Person” means, each of TPG and all of its respective partners, principals, directors, officers, members,
managers, managing directors, advisors, consultants and employees, TPG’s Affiliates, the TPG Directors, or any officer of the Company that is an Affiliate of TPG. 

“TPG Confidential Information” has the meaning set forth in Section 4.4(a). 

“TPG Directors” has the meaning set forth in Section 3.1(a). 

“Unaffiliated Director” has the meaning set forth in Section 3.1(a). 

“Underwriting Agreement” has the meaning set forth in the Recitals. 

Section 1.2 Other Interpretive Provisions. (a) The meanings of defined terms are equally applicable to the singular and
plural forms of the defined terms. 
 (b) The words “hereof,” “herein,” “hereunder” and
similar words refer to this Agreement as a whole and not to any particular provision of this Agreement; and any subsection and section references are to this Agreement unless otherwise specified. 

(c) The term “including” is not limiting and means “including without limitation.” 

(d) The captions and headings of this Agreement are for convenience of reference only and shall not affect the interpretation of this
Agreement. 
 (e) Whenever the context requires, any pronouns used herein shall include the corresponding masculine, feminine or neuter
forms. 

  
 4 

 ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Each of the parties to this Agreement hereby represents and warrants to each other party to this Agreement that as of the date such party
executes this Agreement: 
 Section 2.1 Existence; Authority; Enforceability. Such party has the power and authority to enter
into this Agreement and to carry out its obligations hereunder. Such party is duly organized and validly existing under the laws of its jurisdiction of organization, and the execution of this Agreement, and the consummation of the transactions
contemplated herein, have been authorized by all necessary action on the part of its board of directors (or equivalent) and shareholders (or other holders of equity interests), if required, and no other act or proceeding on its part is necessary to
authorize the execution of this Agreement or the consummation of any of the transactions contemplated hereby. This Agreement has been duly executed by such party and constitutes its legal, valid and binding obligation, enforceable against it in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally or by equitable principles relating to enforceability. 

Section 2.2 Absence of Conflicts. The execution and delivery by such party of this Agreement and the performance of its
obligations hereunder does not and will not (a) conflict with, or result in the breach of any provision of the constitutive documents of such party, (b) result in any violation, breach, conflict, default or an event of default (or an event
which with notice, lapse of time, or both, would constitute a default or an event of default), or give rise to any right of acceleration or termination or any additional payment obligation, under the terms of any contract, agreement or permit to
which such party is a party or by which such party’s assets or operations are bound or affected, or (c) violate any law applicable to such party. 

Section 2.3 Consents. Other than as expressly required herein or any consents which have already been obtained, no consent,
waiver, approval, authorization, exemption, registration, license or declaration is required to be made or obtained by such party in connection with (a) the execution, delivery or performance of this Agreement or (b) the consummation of
any of the transactions contemplated herein. 
 ARTICLE III 

GOVERNANCE 

Section 3.1 The Board. 

(a) Composition of Initial Board. Prior to Closing, the Company and the Stockholders shall take all Necessary Action to cause the Board
to be comprised of seven (7) directors, (i) four (4) of whom shall be designated by TPG (each, a “TPG Director”), (ii) one (1) of whom shall be the Chief Executive Officer and (iii) two (2) of whom
shall be unaffiliated directors, each of whom shall meet the independence criteria set forth in Rule 10A-3 under the Exchange Act (each, an “Unaffiliated Director”). At Closing, the two (2) Unaffiliated Directors shall be
Mr. Frederick A. Hessler and Mr. Curtis S. Lane. The foregoing directors shall be divided into three classes of directors, each of whose members shall serve for staggered three-year terms as follows: 

(1) the class I directors shall include Sharad Mansukani, Jeffrey K. Rhodes and Todd B. Sisitsky; 

(2) the class II directors shall include Thomas C. Geiser and Curtis S. Lane; and 

(3) the class III directors shall include Andrew Hayek and Frederick A. Hessler. 

  
 5 

 The initial term of the class I directors shall expire at the Company’s 2014 annual meeting of stockholders
at which directors are elected. The initial term of the class II directors shall expire at the Company’s 2015 annual meeting of stockholders at which directors are elected. The initial term of the class III directors shall expire at the
Company’s 2016 annual meeting at which directors are elected. 
 For the avoidance of doubt, this Section 3.1(a) is applicable solely to the
initial composition of the Board, except that (i) subject to the Company Charter, a director shall remain a member of the class of directors to which he or she was assigned in accordance with this Section 3.1(a) and (ii) the initial
terms of each class of directors shall expire as set forth in this Section 3.1(a), subject to such director’s earlier death, resignation, disqualification or removal. 

(b) Addition to Board Within One Year of Effectiveness. If on or before the first (1st) anniversary of the effectiveness of the
Company’s registration statement on Form S-1 for the IPO (the “First Anniversary of the IPO”), the Company intends to appoint a third (3rd) Unaffiliated Director to the Board and at the time of such appointment TPG, in the
aggregate, beneficially owns less than 50% of the Post-IPO TPG Shares, then on or prior to date of appointment, (i) to the extent TPG has not previously caused one (1) of the TPG Directors to tender his or her resignation from the Board as
set forth in Section 3.1(c) during the period prior to the First Anniversary of the IPO, TPG shall take all Necessary Action to cause one (1) of the TPG Directors to tender his or her resignation from the Board, effective immediately, and
(ii) the Board shall take all Necessary Action to fill the vacancy caused by the resignation of a TPG Director with the Unaffiliated Director or if the Board size was reduced upon such resignation to increase the size of the board by one
(1) director and fill such newly-created directorship with an Unaffiliated Director, as applicable. 
 However, if on or before the
First Anniversary of the IPO, the Company intends to appoint a third (3rd) Unaffiliated Director to the Board and at the time of such appointment TPG, in the aggregate, beneficially owns more than 50% of the Post-IPO TPG Shares, then on or
prior to the date of appointment, the Board shall take all Necessary Action to cause the Board to be increased in size by two (2) directors to nine (9) directors and to fill such newly-created directorships with (i) one
(1) additional Unaffiliated Director and (ii) one (1) additional TPG Director that shall be designated by TPG. 
 (c) TPG
Representation. At each applicable annual or special meeting of stockholders at which directors are to be elected, there shall be included in the slate of nominees recommended by the Board for election as directors that number of individuals
designated by 

  
 6 

 
TPG (each, a “TPG Designee”) that, if elected, will result in TPG having the number of directors serving on the Board indicated in the column titled “Number of TPG
Designees” in the applicable chart immediately below, so long as TPG, in the aggregate, beneficially owns, as of the date that is 120 days before the date of the annual or special meeting of stockholders, as applicable, the percentage Post-IPO
TPG Shares, as calculated by the method set forth in Section 3.1(d) below, indicated in the column titled “Percentage of Post-IPO TPG Shares” in the applicable chart immediately below. 

From and after the Closing, the step down chart immediately below shall be applicable: 

 

					
	 Percentage of Post-IPO TPG Shares
	  	Number of TPG Designees	 
	 50% or greater
	  	 	4	  
	 Less than 50% but greater than or equal to 30%
	  	 	3	  
	 Less than 30% but greater than or equal to 10%
	  	 	2	  
	 Less than 10% but greater than or equal to 3%
	  	 	1	  
	 Less than 3%
	  	 	0	  

 However, if, in accordance with Section 3.1(b), the size of the Board is increased to nine
(9) directors at any time prior to the date on which TPG beneficially owns less than 50% of the Post-IPO TPG Shares, then the step down chart immediately below shall become applicable: 

 

					
	 Percentage of Post-IPO TPG Shares
	  	Number of TPG Designees	 
	 50% or greater
	  	 	5	  
	 Less than 50% but greater than or equal to 30%
	  	 	4	  
	 Less than 30% but greater than or equal to 20%
	  	 	3	  
	 Less than 20% but greater than or equal to 10%
	  	 	2	  
	 Less than 10% but greater than or equal to 3%
	  	 	1	  
	 Less than 3%
	  	 	0	  

 In the event that the size of the Board is increased or decreased at any time (except as provided in Section 3.1(b)),
TPG’s nomination rights under this Section 3(c) shall be proportionately increased or decreased, respectively, rounded up to the nearest whole number of directors. 

(d) Calculation of Percentage of Post-IPO TPG Shares. For purposes of calculating the percentage in the column titled the
“Percentage of Post-IPO TPG Shares” in the applicable chart set forth in Section 3.1(c) above, the “Percentage of Post-IPO TPG Shares” shall be calculated as a percentage in which (i) the numerator is the number of
shares of Common Stock beneficially owned, in the aggregate, by TPG as of the date on which the calculation is made and (ii) the denominator shall be the number of Post-IPO TPG Shares. 

The numerator and the denominator for the calculation of the “Percentage of Post-IPO TPG Shares” as described in paragraph
immediately above in this Section 3.1(d) shall automatically be proportionately adjusted effective upon the consummation of any transaction or series of related transactions (including any stock dividend, distribution, pro-rata redemption or

  
 7 

 
stock repurchase, recapitalization, stock split or comparable transaction but not including any transfer or sale of shares by TPG) that effects a change in the number of shares of Common Stock
then-currently held by TPG or would have been held by TPG as of the Closing, as applicable; provided, that no such adjustment will restore or increase the number of TPG Designees to which TPG is entitled. 

(e) CEO Representation. Subject to the last sentence of Section 3.1(f), if the term of the Chief Executive Officer as a director
on the Board is to expire in conjunction with any annual or special meeting of stockholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election. 

(f) Vacancies. Except as provided for in Section 3.1(c), and to the extent not inconsistent with Section 141(k) of the
General Corporation Law of the State of Delaware and the Company’s Charter, (i) TPG shall have the exclusive right to remove its TPG Directors from the Board, and the Board and TPG shall take all Necessary Action to cause the removal of
any TPG Directors at the request of TPG and (ii) TPG shall have the exclusive right to designate for election to the Board directors to fill vacancies created by reason of death, removal or resignation of its TPG Directors, and the Board and
TPG shall take all Necessary Action to cause any such vacancies to be filled by replacement directors designated by TPG as promptly as reasonably practicable; provided, that, for the avoidance of doubt and notwithstanding anything to the
contrary in this paragraph, TPG shall not have the right to designate a replacement director, and the Board and TPG shall not be required to take any action to cause any vacancy to be filled with any such TPG Designee, to the extent that election or
appointment of such TPG Designee to the Board would result in a number of directors designated by TPG in excess of the number of directors that TPG is then entitled to designate for membership on the Board pursuant to Section 3.1(c). If the
Chief Executive Officer resigns or is terminated for any reason, the Board and TPG shall take all Necessary Action to remove the Chief Executive Officer from the Board and fill such vacancy with the next Chief Executive Officer in office. 

(g) Additional Unaffiliated Directors. For so long as TPG has the right to designate at least one (1) director for nomination
under this Agreement, the Company will take all Necessary Action to ensure that the number of directors serving on the Board shall not exceed nine (9); provided, that the number of directors may be increased if necessary to satisfy the
requirements of applicable laws and stock exchange regulations. 
 (h) Committees. Subject in each case to applicable laws and stock
exchange regulations, (i) TPG shall have the right to have a representative appointed to serve on each committee of the Board for so long as TPG has the right to designate at least one (1) director for election to the Board and
(ii) for so long as TPG beneficially owns, in the aggregate, 30% or more of the Post-IPO TPG Shares, TPG Directors shall, to the extent requested by TPG, constitute the majority of each committee. Subject in each case to applicable laws and
stock exchange regulations, TPG shall have the right to have a representative appointed as an observer to any committee of the Board to which TPG (i) does not elect to have a representative appointed or (ii) is prohibited by applicable
laws or stock exchange regulations from having a representative appointed, in each case for so long as TPG has the right to designate at least one (1) director for nomination under this Agreement. 

  
 8 

 (i) Reimbursement of Expenses. The Company shall reimburse each TPG Director and TPG
Designee for all reasonable and documented out-of-pocket expenses incurred in connection with such director’s or designee’s participation in the meetings of the Board or any committee of the Board, including all reasonable and documented
travel, lodging and meal expenses. 
 (j) Nomination. With respect to any TPG Designee, the Company shall take all Necessary Action
to cause the Board and Nominating and Governance Committee to, if applicable, (i) include such TPG Designee in the slate of nominees recommended by the Board for the applicable class of directors for election by the stockholders of the Company
or (ii) appoint such TPG Designee to fill a vacancy on the Board created by the departure of a TPG Director. The Company agrees to take all Necessary Action to include such TPG Designee in the applicable proxy statement for such stockholder
meeting. 
 (k) Loss of Controlled Company Exemption. Within one (1) year (or any shorter period that may be required by
applicable law or by the applicable rules and regulations of the Securities and Exchange Commission or the applicable stock exchange on which the Common Stock is listed) after the Company ceases to qualify as a “controlled company” as
defined by the applicable stock exchange rules on which the Common Stock is then-currently listed, TPG shall take all Necessary Action to ensure that a sufficient number of the TPG Directors qualify as “independent directors” as defined by
the applicable stock exchange rules to ensure that the Board complies with stock exchange independence requirements. 
 (l) D&O
Insurance. The Company shall obtain customary director and officer indemnity insurance on commercially reasonable terms for each of its directors, and the TPG Directors shall also be provided the benefit of customary director indemnity
agreements. 
 (m) Indemnification Priority. The Company hereby acknowledges that, in addition to the rights provided to each TPG
Director or other indemnified person covered by any such indemnity insurance policy (any such Person, an “Indemnitee”) or any indemnification agreement that such Indemnitee may enter into with the Company from time to time (the
“Indemnification Agreements”), the Indemnitees, may have certain rights to indemnification, advancement of expenses and/or insurance provided by TPG or one or more of its respective Affiliates (collectively, the “Fund
Indemnitors”). Notwithstanding anything to the contrary in any of the Indemnification Agreements or this Agreement, the Company hereby agrees that, to the fullest extent permitted by law, with respect to its indemnification and advancement
obligations to the Indemnitees under the Indemnification Agreements, this Agreement or otherwise, the Company (i) is the indemnitor of first resort (i.e., its and its insurers’ obligations to advance expenses and to indemnify the
Indemnitees are primary and any obligation of the Fund Indemnitors or their insurers to advance expenses or to provide indemnification for the same expenses or liabilities incurred by any of the Indemnitees is secondary and excess), (ii) shall
be required to advance the full amount of expenses incurred by each Indemnitee and shall be liable for the full amount of all losses of each Indemnitee or on his, her or its behalf to the extent legally permitted and as required by this Agreement
and the Indemnification Agreements, without regard to any rights such Indemnitees may have against the Fund Indemnitors or their insurers, and (iii) irrevocably waives and relinquishes, and releases the Fund Indemnitors and such insurers from,
any and all claims against the Fund Indemnitors or such insurers for 

  
 9 

 
contribution, subrogation or any other recovery of any kind in respect thereof. In furtherance and not in limitation of the foregoing, the Company agrees that in the event that any Fund
Indemnitor or its insurer should advance any expenses or make any payment to any Indemnitee for matters subject to advancement or indemnification by the Company pursuant to this Agreement or otherwise, the Company shall promptly reimburse such Fund
Indemnitor or insurer and that such Fund Indemnitor or insurer shall be subrogated to all of the claims or rights of such Indemnitee under the Indemnification Agreements, this Agreement or otherwise, including to the payment of expenses in an action
to collect. The Company agrees that any Fund Indemnitor or insurer thereof not a party hereto shall be an express third party beneficiary of this Section 3.1(m), able to enforce such clause according to its terms as if it were a party hereto.
Nothing contained in the Indemnification Agreements is intended to limit the scope of this Section 3.1(m) or the other terms set forth in this Agreement or the rights of the Fund Indemnitors or their insurers hereunder. 

Section 3.2 Voting Agreement. TPG agrees to cast all votes to which it is entitled in respect of its Company Shares, whether at
any annual or special meeting, by written consent or otherwise, so as to cause to be elected to the Board those individuals designated in accordance with Section 3.1(a)-(g) and to otherwise effect the intent of this Article III. 

Section 3.3 The Boards of Directors of Subsidiaries. The composition of the boards of directors and committees of all other
subsidiaries of the Company shall be as determined by the Board. 
 ARTICLE IV 

GENERAL PROVISIONS 

Section 4.1 Company Charter and Company Bylaws. 

The Company, the Board and TPG agree to take all Necessary Action to amend the Company Charter and Company Bylaws so as to avoid any conflict
with the provisions hereof. 
 Section 4.2 Corporate Opportunities. 

In recognition and anticipation that the TPG Affiliated Persons (i) currently or may in the future serve as directors, officers or agents
of the Company or its direct or indirect subsidiaries, (ii) currently or may in the future have access to information about the Company and its direct or indirect subsidiaries that may, to the fullest extent permitted by applicable law, enhance
each such TPG Affiliated Person’s knowledge and understanding of (A) the industries in which the Company and its direct and indirect subsidiaries operate (collectively, “Acquired Knowledge”), (B) the activities in
which the Company and its direct or indirect subsidiaries now engage, may continue to engage or may in the future engage (which shall include, without limitation, other business activities that overlap with or compete with those in which the Company
and its Affiliates and its direct or indirect subsidiaries may engage directly or indirectly) or (C) related lines of business in which the Company or its direct or indirect 

  
 10 

 
subsidiaries may engage directly or indirectly and (iii) currently or may in the future have an interest in the same or similar areas of corporate opportunity as the Company or its direct or
indirect subsidiaries may have an interest directly or indirectly, the provisions of this Section 4.2 are set forth to regulate and define, to the fullest extent permitted by applicable law, the conduct of certain affairs of the Company and its
direct or indirect subsidiaries with respect to certain classes or categories of business opportunities as they may involve a TPG Affiliated Person, and the powers, rights, duties and liabilities of the Company and its direct or indirect
subsidiaries and their respective direct or indirect partners, members, and stockholders in connection therewith. 
 (a) Notwithstanding any
provision of this Agreement to the contrary, to the fullest extent permitted by applicable law, if any TPG Affiliated Person acquires knowledge of a potential Corporate Opportunity or otherwise is then exploiting any Corporate Opportunity, the
Company and its Affiliates and its direct or indirect subsidiaries shall have no interest or expectancy in such Corporate Opportunity, or in being offered an opportunity to participate in such Corporate Opportunity, and any interest or expectancy in
any Corporate Opportunity or any expectation in being offered the opportunity to participate in any Corporate Opportunity is hereby renounced and waived so that, such TPG Affiliated Person, to the fullest extent permitted by applicable law,
(i) shall have no duty (fiduciary, contractual or otherwise) to communicate or present such Corporate Opportunity to the Company or any of its Affiliates or any of its direct or indirect subsidiaries or any stockholder of the Company;
(ii) shall have the right to hold or pursue, directly or indirectly, any such Corporate Opportunity for TPG’s own account and benefit or TPG may direct such Corporate Opportunity to another person; and (iii) shall not be liable to the
Company, any of its Affiliates or any of its direct or indirect subsidiaries, their respective Affiliates or their respective direct or indirect partners, members, or stockholder, for breach of any duty (fiduciary, contractual or otherwise) as a
stockholder, director or officer of the Company or otherwise by reason of the fact that it pursues or acquires such Corporate Opportunity, directs such Corporate Opportunity to another person or does not communicate information regarding such
Corporate Opportunity to the Company or any of its Affiliates or any of its direct or indirect subsidiaries. 
 (b) The Company hereby
expressly acknowledges and agrees that each of TPG, its Affiliates and affiliated investment funds and any TPG Affiliated Person, has the right to, and shall have no duty (contractual or otherwise) not to, (i) directly or indirectly engage in
the same or similar business activities or lines of business as the Company or any of its direct or indirect subsidiaries engages or proposes to engage, on such Person’s own behalf, or in partnership with, or as an employee, officer, director,
member or shareholder of any other Person, including those lines of business deemed to be competing with the Company or any of its direct or indirect subsidiaries; (ii) do business with any potential or actual customer or supplier of the
Company or any of its Affiliates or its direct or indirect subsidiaries; and (iii) employ or otherwise engage any officer or employee of the Company or any of its Affiliates or direct or indirect subsidiaries. The Company hereby expressly
acknowledges and agrees that neither the Company nor any of its Affiliates or any of its direct or indirect subsidiaries nor any stockholder of the Company shall have any rights in and to the business ventures of TPG, its Affiliates and affiliated
investment funds, or the income or profits derived therefrom. To the fullest extent permitted by law, none of the TPG Affiliated Persons shall be liable to the Company, any of its Affiliates or its direct or indirect subsidiaries, their respective
Affiliates or their respective direct or indirect partners, members, or stockholders, for breach of any duty (fiduciary, contractual or 

  
 11 

 
otherwise) as a stockholder, director or officer of the Company or otherwise by reason that such TPG Affiliated Person is engaging in any activities or lines of business or competing with the
Company or its direct or indirect subsidiaries. 
 (c) The Company hereby acknowledges and agrees that, to the fullest extent permitted by
applicable law, (i) in the event of any conflict of interest between the Company or any of its direct or indirect subsidiaries, on the one hand, and any TPG Affiliated Person, on the other hand, such TPG Affiliated Person (including each TPG
Director, acting in its capacity as a director and/or any TPG Affiliated Person serving as an officer of the Company or any of its direct or indirect subsidiaries, acting in its capacity as an officer) may act in the best interest of TPG and its
Affiliates and (ii) no TPG Affiliated Person (including any TPG Director acting in its capacity as a director, or any other TPG Affiliated Person serving as an officer of the Company or any of its direct or indirect subsidiaries acting in its
capacity as an officer), shall be obligated to (A) reveal to the Company or any of its direct or indirect subsidiaries confidential information belonging to or relating to the business of TPG or its Affiliates or (B) recommend or take any
action in its capacity as stockholder, director or officer of the Company, as the case may be, that prefers the interest of the Company or any of its Subsidiaries over the interest of TPG and its Affiliates, or such TPG Affiliated Person, as the
case may be. 
 (d) The Company hereby acknowledges and agrees that, to the fullest extent permitted by applicable law, the TPG Affiliated
Persons (including each TPG Director, acting in its capacity as a director and/or any TPG Affiliated Person serving as an officer of the Company or any of its direct or indirect subsidiaries, acting in its capacity as an officer) are not restricted
from using Acquired Knowledge in making investment, voting, monitoring, governance or other decisions relating to other entities or securities. 

Section 4.3 Assignment; Benefit. 

(a) The rights and obligations hereunder shall not be assignable without the prior written consent of the other parties hereto. Any attempted
assignment of rights or obligations in violation of this Section 4.3 shall be null and void. 
 (b) This Agreement shall be binding
upon and shall inure to the benefit of the parties hereto, and their respective successors and permitted assigns, and there shall be no third-party beneficiaries to this Agreement other than the Indemnitees, the Fund Indemnitors and any insurer of a
Fund Indemnitor under Section 3.1(m), and the TPG Investors, their Representatives and the TPG Affiliated Persons under Section 4.2. 

Section 4.4 Confidentiality. 

(a) The Company, hereby agrees that it, and any direct or indirect partner, manager, member, stockholder, employee, director, officer or agent
thereof, with the exception of the TPG Affiliated Persons (each, an “Affiliated Person”), shall keep confidential, and shall not disclose to any third Person or use for its own benefit, without prior approval of TPG, any non-public
information with respect to TPG or any of its subsidiaries or Affiliates (including any Person in which TPG holds, or contemplates acquiring, an investment) (“TPG Confidential Information”) that is in the Company’s or such
Affiliated Persons’ possession on the date hereof 

  
 12 

 
or disclosed after the date of this Agreement to the Company or such Affiliated Persons by or on behalf of TPG or its subsidiaries or Affiliates, provided, that the Company and the
Affiliated Persons may disclose any such TPG Confidential Information (i) as has become generally available to the public, was or has come into the Company’s or the Affiliated Persons’ possession on a non-confidential basis, without a
breach of any confidentiality obligations by the Person disclosing such TPG Confidential Information, or has been independently developed by such Person, without use of the TPG Confidential Information, (ii) to the Company’s Affiliates,
directors, officers, representatives, agents and employees and professional advisers who need to know such TPG Confidential Information and agree to keep it confidential on terms consistent with this Section 4.4(a), (iii) to the extent
necessary in order to comply with any law, order, regulation or ruling applicable to the Company or its Affiliates, or to a regulatory agency with applicable jurisdiction, and (iv) as may be required in response to any summons or subpoena or in
connection with any litigation or arbitration, it being agreed that, unless such TPG Confidential Information has been generally available to the public, if such TPG Confidential Information is being requested pursuant to a summons or subpoena or a
discovery request in connection with a litigation, then (x) the Company shall give TPG notice of such request and shall cooperate with TPG at TPG’s request so that TPG may, in its discretion, seek a protective order or other appropriate
remedy, if available, and (y) in the event that such protective order is not obtained (or sought by TPG after notice), the Company (a) shall furnish only that portion of the TPG Confidential Information which, in the written opinion of
counsel, is legally required to be furnished and (b) will exercise its reasonable efforts to obtain adequate assurances that confidential treatment will be accorded such TPG Confidential Information by its recipients. 

(b) The Company grants permission to TPG to use the name and logo of the Company, in marketing materials used by TPG and its Affiliates. TPG
and its Affiliates shall include a trademark attribution notice giving notice of the Company’s ownership of their trademarks in any marketing materials in which the Company’s name and logo appear. 

(c) Notwithstanding anything to the contrary contained in this Agreement, the provisions of this Section 4.4 shall survive termination of
this Agreement with respect to matters arising before or after such termination, and shall remain in full force and effect until such time as such provisions are explicitly waived and revoked by TPG. Such waiver and revocation shall be made in
writing to the Company and shall take effect at the time specified therein or, if no time is specified therein, at the time of receipt thereof by the Company. 

Section 4.5 Termination. If not otherwise stipulated, this Agreement shall terminate automatically (without any action by any
party hereto) as to each Stockholder as of the later of (i) when such Stockholder no longer owns any shares of Common Stock, or (ii) when such Stockholder no longer has the right to nominate any directors to the Board pursuant to Article
III hereof. 
 Section 4.6 Severability. In the event that any provision of this Agreement shall be invalid, illegal or
unenforceable such provision shall be construed by limiting it so as to be valid, legal and enforceable to the maximum extent provided by law and the validity, legality and enforceability of the remaining provisions shall not in any way be affected
or impaired thereby. 

  
 13 

 Section 4.7 Entire Agreement; Amendment. 

(a) This Agreement sets forth the entire understanding and agreement between the parties with respect to the transactions contemplated herein
and supersedes and replaces any prior understanding, agreement or statement of intent, in each case written or oral, of any kind and every nature with respect hereto. This Agreement or any provision hereof may only be amended, modified or waived, in
whole or in part, at any time by an instrument in writing signed by TPG and the Company (whose agreement to such amendment, modification or waiver shall not be unreasonably withheld); provided that to the extent that Other Stockholders become
party hereto, the prior written consent of the holders of the Majority in Interest of the Company Shares then held by the Other Stockholders shall be required for any amendment, modification or waiver that would have a disproportionate and adverse
effect in any material respect on the rights of Other Stockholders under this Agreement relative to the TPG Investors. 
 (b) No waiver of
any breach of any of the terms of this Agreement shall be effective unless such waiver is expressly made in writing and executed and delivered by the party against whom such waiver is claimed. The waiver by any party hereto of a breach of any
provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a waiver of any other or subsequent breach. Except as otherwise expressly provided herein, no failure on the part of any party to
exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by
such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy. 
 Section 4.8
Counterparts. This Agreement may be executed in any number of separate counterparts each of which when so executed shall be deemed to be an original and all of which together shall constitute one and the same agreement. Counterpart signature
pages to this Agreement may be delivered by facsimile or electronic delivery (i.e., by email of a PDF signature page) and each such counterpart signature page will constitute an original for all purposes. 

Section 4.9 Notices. Unless otherwise specified herein, all notices, consents, approvals, reports, designations, requests,
waivers, elections and other communications authorized or required to be given pursuant to this Agreement shall be in writing and shall be given, made or delivered by personal hand-delivery, by facsimile transmission, by electronic mail, by mailing
the same in a sealed envelope, registered first-class mail, postage prepaid, return receipt requested, or by air courier guaranteeing overnight delivery (and such notice shall be deemed to have been duly given, made or delivered (a) on the date
received, if delivered by personal hand delivery, (b) on the date received, if delivered by facsimile transmission, by electronic mail or by registered first-class mail prior to 5:00 p.m. prevailing local time on a Business Day, or if delivered
after 5:00 p.m. prevailing local time on a Business Day or on other than a Business Day, 

  
 14 

 
on the first Business Day thereafter and (c) two (2) Business Days after being sent by air courier guaranteeing overnight delivery), at the following addresses (or at such other address
as shall be specified by like notice): 
 If to the Company to: 

Surgical Care Affiliates, Inc. 

3000 Riverchase Galleria, Suite 500 

Birmingham, AL 35244 
 Attention:
    General Counsel 
 Facsimile:    (205) 439-4929 

E-mail:         rich.sharff@scasurgery.com 

with a copy (which shall not constitute notice) to: 

Cleary Gottlieb Steen & Hamilton LLP 

One Liberty Plaza 
 New York, NY
10006 
 Attention:   David Lopez 

                   Helena Grannis 

Facsimile:   (212) 225-3999 

E-mail:       dlopez@cgsh.com 

                   hgrannis@cgsh.com 

If to TPG to: 
 TPG Global, LLC 

301 Commerce Street, Suite 3300 

Fort Worth, TX 76102 
 Attention:
    Ronald Cami 
 Facsimile:    (415) 743-1501 

E-mail:         rcami@tpg.com 

with a copy (which shall not constitute notice) to: 

Cleary Gottlieb Steen & Hamilton LLP 

One Liberty Plaza 
 New York, NY
10006 
 Attention:    David Lopez 

                    Helena Grannis 

Facsimile:   (212) 225-3999 

E-mail:        dlopez@cgsh.com 

                    hgrannis@cgsh.com 

Section 4.10 Governing Law. THE CORPORATE LAWS OF THE STATE OF DELAWARE WILL GOVERN ALL QUESTIONS CONCERNING THE RELATIVE RIGHTS
OF THE COMPANY AND THE STOCKHOLDERS HEREUNDER TO THE EXTENT SUCH LAWS ARE APPLICABLE. ALL OTHER QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE DOMESTIC LAWS
OF THE STATE OF NEW YORK. 

  
 15 

 Section 4.11 Jurisdiction. ANY ACTION OR PROCEEDING AGAINST THE PARTIES RELATING IN
ANY WAY TO THIS AGREEMENT MAY BE BROUGHT EXCLUSIVELY IN THE COURTS OF THE STATE OF NEW YORK LOCATED IN THE BOROUGH OF MANHATTAN OR (TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFORE) THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN
DISTRICT OF NEW YORK, AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING. ANY ACTIONS OR PROCEEDINGS TO ENFORCE A JUDGMENT ISSUED BY ONE OF THE FOREGOING COURTS MAY BE ENFORCED IN
ANY JURISDICTION. 
 Section 4.12 Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED,
EACH PARTY HERETO WAIVES, AND COVENANTS THAT SUCH PARTY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE, CLAIM OR PROCEEDING ARISING OUT OF THIS AGREEMENT OR THE SUBJECT
MATTER HEREOF OR IN ANY WAY CONNECTED WITH THE DEALINGS OF ANY STOCKHOLDER IN CONNECTION WITH ANY OF THE ABOVE, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER IN CONTRACT, TORT OR OTHERWISE. EACH PARTY HERETO ACKNOWLEDGES THAT IT
HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 4.12 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH IT IS RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. ANY PARTY HERETO MAY FILE AN
ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 4.12 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

Section 4.13 Specific Performance. It is hereby agreed and acknowledged that it will be impossible to measure in money the damages
that would be suffered if the parties fail to comply with any of the obligations herein imposed on them by this Agreement and that, in the event of any such failure, an aggrieved party will be irreparably damaged and will not have an adequate remedy
at law. Any such party shall therefore be entitled (in addition to any other remedy to which such party may be entitled at law or in equity) to injunctive relief, including specific performance, to enforce such obligations, without the posting of
any bond, and if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law. 

Section 4.14 Subsequent Acquisition of Shares. Any equity securities of the Company acquired subsequent to the date hereof by a
Stockholder shall be subject to the terms and conditions of this Agreement. 
 [Signature pages follow] 

  
 16 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the day and year first
above written. 
  

			
	SURGICAL CARE AFFILIATES, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

 [Signature Page to Stockholders Agreement] 

  

			
	TPG PARTNERS V, L.P.
		
	By:	 	TPG GenPar V, L.P.,
		 	its general partner
	By:	 	TPG GenPar V Advisors, LLC,
		 	its general partner
		
	By:	 	  

	Name:	 	Ronald Cami
	Title:	 	Vice President
	
	TPG FOF V-A, L.P.
		
	By:	 	TPG GenPar V, L.P.,
		 	its general partner
	By:	 	TPG GenPar V Advisors, LLC,
		 	its general partner
		
	By:	 	  

	Name:	 	Ronald Cami
	Title:	 	Vice President
	
	TPG FOF V-B, L.P.
		
	By:	 	TPG GenPar V, L.P.,
		 	its general partner
	By:	 	TPG GenPar V Advisors, LLC,
		 	its general partner
		
	By:	 	  

	Name:	 	Ronald Cami
	Title:	 	Vice President

 [Signature Page to Stockholders Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}]]